Aeon Biopharma Inc (AEON) Stock Price, Quote & News

Company Profile

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceu...

Industry: Biotechnology

Sector: Healthcare

Phone: 949 354 6499

Website: www.aeonbiopharma.com

Address:

5 Park Plaza, Suite 1750, Irvine, United States

BryceyBoy Jan. 14 at 4:31 PM

$AEON Finally some movement! Still bullish

0 · Reply

flywithfitz81 Jan. 13 at 1:08 PM

$AEON looking to do something today?

0 · Reply

flywithfitz81 Jan. 13 at 8:48 AM

$PSTV $SPCB $CNC $FISV $AEON Concrete day. That means it is time to order supplies, which are very expensive. Let's do better this week, please? Daddy needs some green, or I have to sell one of the children.

2 · Reply

VXRT007 Jan. 13 at 5:56 AM

$AEON If this stock starts to run in a couple weeks make sure you understand why the resistance levels are pushed to$6-7 dollars. If you panic sell at $2-3 dollars you may miss out. I am not an expert but its pretty clear to me why the analyst set these targets.

0 · Reply

TWITLIEDETECTOR Jan. 13 at 2:40 AM

$AEON interesting filing today. please read at your own pleasure

0 · Reply

BryceyBoy Jan. 12 at 6:00 PM

$AEON What is everyones thoughts for this week? Will we stay around the 1.05 to 1.20? Or are we going to continue to rise?

1 · Reply

flywithfitz81 Jan. 12 at 6:52 AM

$AEON Looks like the price is being maintaned at or above above $1.08. Someone doesn't want this falling below $1.00. Seems a stable platform for swinging. Likely to start a run before the next regulatory update at EOM. Anything below $1.05 is swinging. Enter $1.04 exit $1.12. Using trailing limit in case it blows through $1.12 at opening.

0 · Reply

TWITLIEDETECTOR Jan. 11 at 8:18 PM

$AEON why is there no shorts on here? it’s great but there’s nobody bashing. i guess that’s good. can anyone see how much this is being shorted?

3 · Reply

VXRT007 Jan. 11 at 8:11 AM

$AEON Currently Looks like it only needs to get past $1.80 to run to $6

2 · Reply

SuperGreenToday Jan. 10 at 3:26 AM

$AEON

0 · Reply

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

Dec 15, 2025, 4:05 PM EST - 4 weeks ago

AEON Biopharma Announces Execution of Exchange Agreement with Daewoong

Nov 20, 2025, 8:30 AM EST - 7 weeks ago

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling

Nov 14, 2025, 8:30 AM EST - 2 months ago

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

Nov 13, 2025, 8:30 AM EST - 2 months ago

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes

Oct 1, 2025, 8:00 AM EDT - 3 months ago

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19

Aug 12, 2025, 4:05 PM EDT - 5 months ago

AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update

May 19, 2025, 4:05 PM EDT - 8 months ago

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025

May 14, 2025, 4:05 PM EDT - 8 months ago

AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

Apr 25, 2025, 4:05 PM EDT - 9 months ago

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Apr 21, 2025, 4:05 PM EDT - 9 months ago

AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer

Mar 27, 2025, 4:05 PM EDT - 10 months ago

AEON Biopharma Announces CEO Transition

Mar 24, 2025, 4:05 PM EDT - 10 months ago

AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 4, 2025, 8:00 AM EST - 11 months ago

AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference

Feb 24, 2025, 2:00 PM EST - 11 months ago

AEON Biopharma, Inc. Announces Reverse Stock Split

Feb 7, 2025, 4:05 PM EST - 1 year ago

AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Jan 7, 2025, 9:37 AM EST - 1 year ago

AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering

Jan 3, 2025, 8:02 PM EST - 1 year ago

AEON Biopharma, Inc. Announces Launch of Proposed Public Offering

Nov 13, 2024, 4:05 PM EST - 1 year ago

AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Aug 19, 2024, 4:05 PM EDT - 1 year ago

AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024

Aug 12, 2024, 4:05 PM EDT - 1 year ago

AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

May 29, 2024, 8:00 AM EDT - 1 year ago

AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan

May 14, 2024, 4:05 PM EDT - 1 year ago

AEON Biopharma Reports First Quarter 2024 Financial Results

May 9, 2024, 8:00 AM EDT - 1 year ago

AEON Biopharma Provides Update on Development Pipeline

May 3, 2024, 7:00 AM EDT - 1 year ago

AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine

Mar 30, 2024, 10:53 PM EDT - 1 year ago

CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants

Mar 29, 2024, 4:15 PM EDT - 1 year ago

AEON Biopharma Announces Redemption of Public Warrants

Mar 29, 2024, 3:45 PM EDT - 1 year ago

AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 19, 2024, 4:30 PM EDT - 1 year ago

AEON Biopharma Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Migraine

Mar 19, 2024, 4:29 PM EDT - 1 year ago

AEON Biopharma Announces $15 Million Financing Transaction and Termination of Forward Purchase Agreements

Jan 18, 2024, 4:05 PM EST - 2 years ago

AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin Conference

Dec 12, 2023, 8:00 AM EST - 2 years ago

AEON Biopharma Completes Enrollment in Phase 2 Study of ABP-450 (prabotulinumtoxinA) for Preventive Treatment of Chronic Migraine

Nov 13, 2023, 8:15 AM EST - 2 years ago

AEON Biopharma Reports Third Quarter 2023 Financial Results

Oct 19, 2023, 4:05 PM EDT - 2 years ago

AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine

Aug 29, 2023, 8:00 AM EDT - 2 years ago

AEON Biopharma Presents Positive Results from Phase 2 Clinical Trial of ABP-450 (prabotulinumtoxinA) in Cervical Dystonia at the International Parkinson and Movement Disorders Society Congress®

Aug 24, 2023, 8:00 AM EDT - 2 years ago

AEON Biopharma Receives Notice of Allowance from USPTO for a Patent Covering Use of Botulinum Toxins to Treat Migraine Headache

Aug 16, 2023, 7:00 AM EDT - 2 years ago

Strathspey Crown Holdings Group, LLC Provides Clarifying Statement Regarding Form 4 Filing with SEC for Holdings in AEON Biopharma

Jul 24, 2023, 7:00 AM EDT - 2 years ago

AEON Biopharma Announces Closing of Business Combination with Priveterra Acquisition Corp. and Provides Pipeline Update

BryceyBoy Jan. 14 at 4:31 PM

$AEON Finally some movement! Still bullish

0 · Reply

flywithfitz81 Jan. 13 at 1:08 PM

$AEON looking to do something today?

0 · Reply

flywithfitz81 Jan. 13 at 8:48 AM

2 · Reply

VXRT007 Jan. 13 at 5:56 AM

0 · Reply

TWITLIEDETECTOR Jan. 13 at 2:40 AM

$AEON interesting filing today. please read at your own pleasure

0 · Reply

BryceyBoy Jan. 12 at 6:00 PM

$AEON What is everyones thoughts for this week? Will we stay around the 1.05 to 1.20? Or are we going to continue to rise?

1 · Reply

flywithfitz81 Jan. 12 at 6:52 AM

0 · Reply

TWITLIEDETECTOR Jan. 11 at 8:18 PM

$AEON why is there no shorts on here? it’s great but there’s nobody bashing. i guess that’s good. can anyone see how much this is being shorted?

3 · Reply

VXRT007 Jan. 11 at 8:11 AM

$AEON Currently Looks like it only needs to get past $1.80 to run to $6

2 · Reply

SuperGreenToday Jan. 10 at 3:26 AM

$AEON

0 · Reply

BigD_Love Jan. 9 at 6:10 PM

$AEON Damn, on 25k shares traded today… C’mon , man!

2 · Reply

Mandi63 Jan. 9 at 4:08 PM

$AEON Shareholder meeting to be held January 21…same day as FDA meeting.

2 · Reply

flywithfitz81 Jan. 9 at 9:32 AM

$AEON what genius has his bid set $0.05 lower than ticker price. Don't push a sale overnight. This is basics.

0 · Reply

TWITLIEDETECTOR Jan. 9 at 12:26 AM

$AEON new trading channel 1.04 to 1.14

0 · Reply

Dfastpitchchic5 Jan. 8 at 9:47 PM

$AEON $QCLS $PMCB $YYAI

2 · Reply

TWITLIEDETECTOR Jan. 8 at 8:28 PM

$AEON look at the 1.09 sticking. just like the last filing stated. my bet is it still loses support and we get another $1.02 dip

1 · Reply

TWITLIEDETECTOR Jan. 8 at 7:03 PM

$AEON well the RS threat is gone

0 · Reply

flywithfitz81 Jan. 8 at 6:32 PM

$SPCB $PSTV $AEON Well, at least you tried.

0 · Reply

flywithfitz81 Jan. 8 at 6:29 PM

$CNC $FISV $AEON $SPCB $PSTV Centene has a wide lead, but Fiserv is looking to close ground.

0 · Reply

inmarketswetrust Jan. 8 at 5:10 PM

$AEON Wondering why is it down so much? Someone knows something?

3 · Reply

TWITLIEDETECTOR Jan. 8 at 4:10 PM

$AEON 1.02

0 · Reply

Dfastpitchchic5 Jan. 8 at 3:25 PM

$AEON

0 · Reply

Market Cap	13.03M
Revenue (ttm)	0.00
Net Income (ttm)	42.01M
EPS (ttm)	N/A
PE Ratio	0.40
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	205,782
Avg Vol	216,370
Day's Range	N/A - N/A
Shares Out	11.84M
Stochastic %K	30%
Beta	0.72
Analysts	Strong Sell
Price Target	$6.10